Transrail Lighting Limited IPO...
19 Dec 2024
Hamps Bio Limited IPO
Hamps Bio Limited, incorporated in 2007, is a dynamic company that is engaged in marketing & distribution of a diverse pharmaceutical product range, like syrups, injectables, capsules, oils, nutritional supplements and more. Having a steadfast commitment to innovation and quality, Hamps BIO has also established itself as a trusted name within the pharmaceutical industry.
Distribution Network:
Hamps Bio Limited boasts an extensive distribution network encompassing approximately 50 distributors and varied e-commerce platforms. The products they offer are available on varied reputable online marketplaces, including Amazon in the EU, Canada, and the US. Apart from that, the products are also available in India on Jio Mart and Flipkart. Maintaining expansive reach with the offered products ensures that the pharma offerings by Hamps Bio remain accessible to a broad consumer range. Their pharma products are sold across the eight states and the Indian Union territories. Moreover, their freeze-dried and frozen products have a broader geographical reach, extending to 22 states and union territories of 6 countries.
Business Segments:
Hamps Bio Limited's operations have been strategically divided into two major segments:
Pharmaceuticals
Operating under the "Hamps" brand, the company's pharmaceutical division delivers a comprehensive product array. Such a segment includes syrups, tablets, injectables, capsules, and also powders. All of it is meticulously crafted to meet high standards of both safety and efficacy.
Freeze-dried and Frozen Products
The FMCG division of the company focuses on freeze-dried & frozen items. These are marketed under the "FzyEzy" brand. Hamps Bio today operates via both B2C and B2B models, offering products under the brand and even engaging within contract manufacturing. The freeze-dried & frozen product line includes varied options like strawberries, mango, jamun and chikoo powder, catering to both international and domestic demands.
To summarize, Hamps Bio Limited continues its expansion today by having a footprint in not just pharmaceutical but also FMCG sectors. It is driven by innovation & customer satisfaction.
Hamps Bio IPO Overview:
- ● Issue Type: Fixed Price Issue IPO
- ● IPO Size: ₹6.22 crores
- ○ Fresh Issue: 12.2 lakh shares
- ● Price Per Share: ₹51
- ● Minimum Lot Size: 2000 shares
- ● IPO Opening Date: December 13, 2024
- ● IPO Closing Date: December 17, 2024
- ● Book Running Lead Managers: Marwadi Chandarana Intermediaries Brokers Pvt. Ltd.
- ● Registrar: Bigshare Services Pvt. Ltd.
- ● Market Maker: Pure Broking
WHAT IS GMP?
GMP (Grey Market Premium) is the difference between the IPO price and the grey market price. It is the premium amount paid for the traded IPO shares. It plays an important role in IPOs as it reflects how the IPO would react on the listing day.
A grey market is a place where shares/stocks are traded before being listed officially on the stock exchange.
Hamps Bio Limited GMP
| GMP Date | IPO Price | GMP | Last Updated |
|---|---|---|---|
| - | 51 | - | - |
**The GMP prices displayed here are solely for informational purposes related to the grey market news. India IPO does not engage in or facilitate grey market trading, nor are these rates (sub2) indicative of any trading activity. We also do not recommend or endorse participation in the grey market.**
Hamps Bio IPO Details
| Detail | Description |
|---|---|
| IPO Date | December 13, 2024 to December 17, 2024 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | ₹51 per share |
| Lot Size | 2000 Shares |
| Total Issue Size | 1,220,000 shares (aggregating up to ₹6.22 Cr) |
| Fresh Issue | 1,220,000 shares (aggregating up to ₹6.22 Cr) |
| Issue Type | Fixed Price Issue IPO |
| Listing At | BSE SME |
| Shareholding pre issue | 3,136,000 |
| Shareholding post issue | 4,356,000 |
| Market Maker portion | 62,000 shares Pure Broking |
Hamps Bio IPO Timeline (Tentative Schedule)
| Detail | Description |
|---|---|
| IPO Open Date | Friday, December 13, 2024 |
| IPO Close Date | Tuesday, December 17, 2024 |
| Basis of Allotment | Wednesday, December 18, 2024 |
| Initiation of Refunds | Thursday, December 19, 2024 |
| Credit of Shares to Demat | Thursday, December 19, 2024 |
| Listing Date | Friday, December 20, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on December 17, 2024 |
Hamps Bio IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 2000 | ₹102,000 |
| Retail (Max) | 1 | 2000 | ₹102,000 |
| HNI (Min) | 2 | 4,000 | ₹204,000 |
Hamps Bio IPO Promoter Holding
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 75% of the Net Issue |
| Retail Shares Offered | Not less than 10% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
Hamps Bio IPO Promoter Holding
| Share Holding Pre Issue | 100% |
| Share Holding Post Issue | 71.99% |
Competitive Strength:
- ● Expert Leadership and Industry Experience Driving Strategic Business Growth.
- ● Distribution Network with an Expansive E-Retailing Presence.
- ● Wide and diversified range of products.
- ● Diversified, global customer base with long-standing relationships.
- ● Wide Geographical Presence.
- ● Brand Identity.
Hamps Bio Limited Financial Information
| Period Ended | 30 Oct 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 | ||||||||||||||||||||||||||||||||||||
| Assets | 644.00 | 514.77 | 395.87 | 364.31 | ||||||||||||||||||||||||||||||||||||
| Revenue | 436.42 | 650.13 | 558.49 | 534.46 | ||||||||||||||||||||||||||||||||||||
| Profit After Tax | 34.08 | 50.07 | 35.90 | 12.15 | ||||||||||||||||||||||||||||||||||||
| Net Worth | 370.78 | 337.42 | 136.30 | 100.57 | ||||||||||||||||||||||||||||||||||||
| Reserves and Surplus | 57.18 | 141.42 | -13.70 | -49.43 | ||||||||||||||||||||||||||||||||||||
| Total Borrowing | 138.31 | 104.52 | 173.77 | 204.31 | ||||||||||||||||||||||||||||||||||||
| Amount in ₹ Lakhs | ||||||||||||||||||||||||||||||||||||||||
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 21.14% |
| ROCE | 18.31% |
| RoNW | 14.84% |
| Debt/Equity | 0.31 |
| P/BV | 2.96 |
| PAT Margin (%) | 7.73 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 1.6 | 1.34 |
| P/E (x) | 31.94 | 38.03 |
Hamps Bio IPO Objectives:-
-
The Company intends to use its proceeds as follows:
- 1. Purchase of plant & machinery for FMCG division.
- 2. Enhancing the visibility and awareness of the brand.
- 3. General corporate purposes.
Hamps Bio IPO FAQs
-
What is Hamps Bio IPO?
Hamps Bio IPO is a SME IPO. The company is going to raise ₹6.22 Crores via IPO. The issue is priced at ₹51 per equity share. The IPO is to be listed on BSE.
-
When will Hamps Bio IPO open for subscription?
The IPO is to open on December 13, 2024 for QIB, NII, and Retail Investors. The IPO will close on December 17, 2024.
-
What is Hamps Bio IPO Investors Portion?
The investors’ portion for QIB is 00%, NII is 50%, and Retail is 50%.
-
What is Hamps Bio IPO Issue Size?
Hamps Bio IPO issue size is ₹6.22 crores.
-
What is Hamps Bio IPO Price Band?
Hamps Bio IPO Price Band is ₹51.
-
What is Hamps Bio IPO Lot Size?
The minimum bid is 2000 Shares with ₹102,000.
-
What is the Hamps Bio IPO Allotment Date?
Hamps Bio IPO allotment date is December 18, 2024.
-
What is the Hamps Bio IPO Listing Date?
Hamps Bio IPO listing date is December 20, 2024. The IPO is to be listed on BSE.
-
What is the Hamps Bio current GMP?
The current GMP of the Hamps Bio is ---.
Read More IPO related blogs- International Gemmological Institute (India) Limited IPO
_Limited_IPO_right.jpg)
_Limited_IPO_right.jpg)
_Mobility_&_Hospitality_Limited_IPO_right.jpg)
